STAGE IV GALLBLADDER CANCER AJCC V8
Clinical trials for STAGE IV GALLBLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV GALLBLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV GALLBLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on biliary cancers: targeted drug plus chemo shows promise
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (mFOLFOX6) can shrink tumors or extend survival in people with advanced biliary tract cancers that have certain genetic changes (MAPK pathway alterations). About 66 participants whose cancer wo…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Three-Drug combo aims to shrink Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs (peposertib and avelumab) plus a special type of radiation (hypofractionated) in people with advanced solid tumors or liver/bile duct cancers that have spread. The goal is to find the safest dose and see if the combination can shrink tu…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC